MicrobiologybioRxivPreprint
Incorporation of native HCV E1E2 into a nanoparticle vaccine platform
Liudmila Kulakova, Sarah Jeong, Dong-Xiu Zhang…·Thomas R. Fuerst
This paper develops a nanoparticle vaccine platform incorporating native HCV E1E2 to enhance immunogenicity, showing improved neutralizing antibody responses compared to subunit vaccines.
DOI 10.64898/2026.08.05.743069